ACM Biolabs Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.87M
- Investors
-
7
ACM Biolabs General Information
Description
Operator of a biotechnology company intended to develop novel vaccines using proprietary artificial cell membrane technology. The company develops prophylactic and therapeutic vaccines for infectious diseases and therapeutic vaccines for personalized cancer treatment, enabling medical researchers to develop effective vaccines.
Contact Information
Website
www.acmbiolabs.comCorporate Office
- 71 Nanyang Drive
- Suite 02M-02 NTU Innovation Centre
- Singapore, 638075
- Singapore
Corporate Office
- 71 Nanyang Drive
- Suite 02M-02 NTU Innovation Centre
- Singapore, 638075
- Singapore
ACM Biolabs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 08-May-2025 | $2.87M | Completed | Clinical Trials - Phase 1 | ||
| 8. Later Stage VC (Series B1) | 20-Sep-2022 | Completed | Clinical Trials - Phase 1 | |||
| 7. Later Stage VC (Series B) | 19-Aug-2021 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC (Series A1) | 14-Jan-2021 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC (Series A) | 03-Mar-2020 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 01-Jul-2015 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 2. Spin-Off | 26-Jun-2013 | Completed | Pre-Clinical Trials | |||
| 1. University Spin-Out | 01-Jan-2013 | Completed | Pre-Clinical Trials |
ACM Biolabs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B1 | ||||||||
| Series B | ||||||||
| Series A1 | ||||||||
| Series A | 652,100 | $4 | $4 | 1x | $4 | 8.1% | ||
| Seed | 1,024,291 | $2.71 | $2.71 | 1x | $2.71 | 12.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ACM Biolabs Patents
ACM Biolabs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023226175-A1 | Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof | Pending | 23-Feb-2022 | ||
| EP-4482477-A1 | Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof | Pending | 23-Feb-2022 | ||
| US-20250235532-A1 | Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof | Pending | 23-Feb-2022 | ||
| WO-2023161378-A1 | Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof | Inactive | 23-Feb-2022 | ||
| AU-2022258552-A1 | Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof | Pending | 12-Apr-2021 | A61K9/1273 |
ACM Biolabs Signals
ACM Biolabs Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Coalition for Epidemic Preparedness Innovations | Impact Investing | Minority | ||
| Nagase Future Investments | Corporate Venture Capital | Minority | ||
| RITZ Venture Capital | Venture Capital | Minority | ||
| Shenzhen Yifeng Investment Management Enterprise | Venture Capital | Minority | ||
| San Pacific Investments | Family Office | Minority |
ACM Biolabs Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ACM Biosciences | Basel, Switzerland | 2020 |
ACM Biolabs FAQs
-
When was ACM Biolabs founded?
ACM Biolabs was founded in 2013.
-
Where is ACM Biolabs headquartered?
ACM Biolabs is headquartered in Singapore, Singapore.
-
What is the size of ACM Biolabs?
ACM Biolabs has 19 total employees.
-
What industry is ACM Biolabs in?
ACM Biolabs’s primary industry is Drug Discovery.
-
Is ACM Biolabs a private or public company?
ACM Biolabs is a Private company.
-
What is ACM Biolabs’s current revenue?
The current revenue for ACM Biolabs is .
-
How much funding has ACM Biolabs raised over time?
ACM Biolabs has raised $26M.
-
Who are ACM Biolabs’s investors?
Coalition for Epidemic Preparedness Innovations, Nagase Future Investments, RITZ Venture Capital, Shenzhen Yifeng Investment Management Enterprise, and San Pacific Investments are 5 of 7 investors who have invested in ACM Biolabs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process